Proceedings: Pathways for Successful Translation of New Imaging Agents and Modalities—Phase III Studies

Autor:	Munir Ghesani, Thomas A. Hope, Jason M. Warram, Sanjiv S. Gambhir, Lalitha K. Shankar, Barry A. Siegel, Gunilla B. Jacobson, Paula M. Jacobs, Eben L. Rosenthal, Terri Wilson
Rok vydání:	2019
Předmět:	Male medicine.medical_specialty 030232 urology & nephrology Medicare Translational Research Biomedical 03 medical and health sciences 0302 clinical medicine Inventions Government regulation Humans Medicine Radiology Nuclear Medicine and imaging Medical physics Modalities United States Food and Drug Administration business.industry Prostatic Neoplasms United States Molecular Imaging Clinical trial Clinical Trials Phase III as Topic Surgery Computer-Assisted 030220 oncology & carcinogenesis Special Contribution Government Regulation Molecular imaging business
Zdroj:	Journal of Nuclear Medicine. 60:736-744
ISSN:	2159-662X 0161-5505
DOI:	10.2967/jnumed.118.219824
Popis:	Significant advances continue in the development of cancer-specific molecular imaging agents and modalities for diagnosing, staging, and treating various cancer types. For these advances to translate successfully to widespread clinical use, both regulatory approval by the U.S. Food and Drug
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5e3ed631aa62dc72e88aedea17085da https://doi.org/10.2967/jnumed.118.219824 Zobrazit plný text záznamu